PharmacyCodes



Cefpiramidum [INN-Latin] en es it fr

Cefpiramidum [INN-Latin] Brand names, Cefpiramidum [INN-Latin] Analogs

Cefpiramidum [INN-Latin] Brand Names Mixture

  • No information avaliable

Cefpiramidum [INN-Latin] Chemical_Formula

C25H24N8O7S2

Cefpiramidum [INN-Latin] RX_link

No information avaliable

Cefpiramidum [INN-Latin] fda sheet

Cefpiramidum [INN-Latin] msds (material safety sheet)

Cefpiramidum [INN-Latin] Synthesis Reference

No information avaliable

Cefpiramidum [INN-Latin] Molecular Weight

612.64 g/mol

Cefpiramidum [INN-Latin] Melting Point

No information avaliable

Cefpiramidum [INN-Latin] H2O Solubility

No information avaliable

Cefpiramidum [INN-Latin] State

Solid

Cefpiramidum [INN-Latin] LogP

-0.294

Cefpiramidum [INN-Latin] Dosage Forms

Injection and infusion

Cefpiramidum [INN-Latin] Indication

For treatment of severe infections caused by susceptible bacteria.

Cefpiramidum [INN-Latin] Pharmacology

Cefpiramide is a cephalosporin active against Pseudomonas aeruginosa. It has a broad spectrum of antibacterial activity. Cefpiramide works by inhibiting bacterial cell wall biosynthesis. The plasma half-lives of cefpiramide in rabbits, dogs, and rhesus monkeys were much longer than those of cefoperazone and cefazolin.

Cefpiramidum [INN-Latin] Absorption

Rapidly absorbed following intramuscular injection.

Cefpiramidum [INN-Latin] side effects and Toxicity

Adverse effects following overdosage include nausea, vomiting, epigastric distress, diarrhea, and convulsions.

Cefpiramidum [INN-Latin] Patient Information

No information avaliable

Cefpiramidum [INN-Latin] Organisms Affected

Enteric bacteria and other eubacteria